{{Rsnum
|rsid=649392
|Gene=CCND1
|Chromosome=11
|position=69650025
|Orientation=plus
|GMAF=0.4123
|Gene_s=CCND1,LOC100996515
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.2 | 44.2 | 18.6
| HCB | 74.5 | 24.1 | 1.5
| JPT | 76.1 | 23.0 | 0.9
| YRI | 12.2 | 46.3 | 41.5
| ASW | 17.5 | 43.9 | 38.6
| CHB | 74.5 | 24.1 | 1.5
| CHD | 75.2 | 24.8 | 0.0
| GIH | 36.6 | 46.5 | 16.8
| LWK | 11.8 | 48.2 | 40.0
| MEX | 22.4 | 43.1 | 34.5
| MKK | 14.1 | 50.0 | 35.9
| TSI | 32.4 | 51.0 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}